Viewing Study NCT04274166


Ignite Creation Date: 2025-12-24 @ 4:18 PM
Ignite Modification Date: 2026-02-03 @ 11:20 PM
Study NCT ID: NCT04274166
Status: WITHDRAWN
Last Update Posted: 2021-05-28
First Post: 2020-02-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum
Sponsor: Wake Forest University Health Sciences
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pyoderma Gangrenosum View
Keywords: